Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy.

Udwadia, Zarir F; Pawar, Unmesha Prakash; Nanda, Viral Jayshinh

Udwadia, Zarir F; Pawar, Unmesha Prakash; Nanda, Viral Jayshinh.

Afiliación

Udwadia ZF; Consultant Chest Physician, P.D. Hinduja Hospital and MRC, Mumbai, India.
Pawar UP; Clinical Assistant, P.D. Hinduja Hospital and MRC, Mumbai, India.
Nanda VJ; Clinical Assistant, P.D. Hinduja Hospital and MRC, Mumbai, India.

Lung India ; 39(6): 587-588, 2022.

Article en En | MEDLINE | ID: mdl-36629242

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746276
https://dx.doi.org/10.4103/lungindia.lungindia_355_22

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Lung India Año: 2022 Tipo del documento: Article País de afiliación: India